Phase 2 Psoriatic Arthritis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been formally diagnosed with Psoriatic Arthritis (PsA) and meet a specific set of classification criteria for that condition, with symptoms that started at least 6 months before the screening visit.
• People who have active plaque psoriasis (a skin condition causing raised, scaly patches) or a documented history of it.
• People who have either never been treated with a biologic medication for their condition, or who have tried biologic medications but did not respond well enough or could not tolerate them.

Who may not be able to join:

• People who had any form of arthritis that began before age 17, or who have been diagnosed with a different inflammatory joint condition (such as rheumatoid arthritis or lupus) alongside or instead of PsA.
• People who have a skin condition other than psoriasis that could affect how the trial team assesses psoriasis symptoms.
• People who have had a cancer diagnosis within the last 5 years — though fully treated non-melanoma skin cancers or certain treated cervical conditions may not apply (confirm with trial site).
• People who have any active infection at the time of joining the trial.
• People who have a known allergy, sensitivity, or intolerance to the study drug (tulisokibart) or any of its ingredients.

Important: Always verify eligibility with the trial site directly before applying.